Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Ido Lubin"'
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTA preliminary study investigating immunotherapy strategies for aggressive triple negative breast cancer (TNBC) revealed an overexpression of genes involved in the release of extracellular vesicles (EVs). Proteins expressed by EVs play a role
Externí odkaz:
https://doaj.org/article/a3a1a130abb9444b8830f3ce9e913360
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Breast cancer treatment is tailored to the specific cancer subtype. Often, systemic treatment is given prior to surgery. Chemotherapy induces significant endoplasmic reticulum (ER) stress-mediated cell death and upregulation of 78
Externí odkaz:
https://doaj.org/article/03b6b01526a14e72b08313e78161882f
Autor:
Annat Raiter, Oran Zlotnik, Julia Lipovetsky, Shany Mugami, Shira Dar, Ido Lubin, Eran Sharon, Cyrille J. Cohen, Rinat Yerushalmi
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Breast cancer subtypes have not shown significant response to current immunomodulatory therapies. Although most subtypes are treatable, triple negative breast cancer (TNBC), an aggressive highly metastatic cancer, comprising 10–20% of breast cancer
Externí odkaz:
https://doaj.org/article/e691ba8d4151439382e9e71a4839d3d4
Autor:
Lilach Moyal, Nataly Feldbaum, Neta Goldfeiz, Ada Rephaeli, Abraham Nudelman, Michal Weitman, Nataly Tarasenko, Batia Gorovitz, Leah Maron, Shiran Yehezkel, Iris Amitay-Laish, Ido Lubin, Emmilia Hodak
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146115 (2016)
The 2 histone deacetylase inhibitors (HDACIs) approved for the treatment of cutaneous T-cell lymphoma (CTCL) including mycosis fungoides/sezary syndrome (MF/SS), suberoylanilide hydroxamic acid (SAHA) and romidepsin, are associated with low rates of
Externí odkaz:
https://doaj.org/article/9ab3cb25672a40d497fe1695f1a53697
Autor:
Anat Gafter-Gvili, Boris Zingerman, Benaya Rozen-Zvi, Yaacov Ori, Hefziba Green, Ido Lubin, Tsipora Malachi, Uzi Gafter, Michal Herman-Edelstein
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68341 (2013)
BACKGROUND:DNA repair is a cellular defence mechanism responding to DNA damage caused in large part by oxidative stress. There is a controversy with regard to the effect of red blood cells on DNA damage and cellular response. AIM:To investigate the e
Externí odkaz:
https://doaj.org/article/540c121bc35143089b0e8318f9bca3a0
Autor:
Saar Shapira, Smadar Avigad, Aladin Samara, Ofer Shpilberg, Galit Granot, Pia Raanani, Ido Lubin
Publikováno v:
British Journal of Haematology. 192:747-760
Mantle cell lymphoma (MCL) is a difficult-to-treat B-cell malignancy characterized by cyclin D1 (CD1) overexpression. Targeting CD1 in MCL has been shown to be of therapeutic significance. However, treatment of MCL remains challenging since patients
Autor:
Amir Tiroler, Dvora Namdar, Guy Drori, Hinanit Koltai, Lilach Moyal, Stalin Nadarajan, Emmilia Hodak, Iris Amitay-Laish, Adi Faigenboim, Moran Mazuz, Owen Van Cauwenberghe, Avi Drori, Ajjampura C. Vinayaka, Ido Lubin, Batia Gorovitz-Haris
Publikováno v:
Oncotarget. 11:1141-1156
Cannabis sativa produces hundreds of phytocannabinoids and terpenes. Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma (CTCL), characterized by patches, plaques and tumors. Sezary is a leukemic stage of CTCL presenting with
Autor:
Rinat Yerushalmi, Oran Zlotnik, Shira Dar, Ido Lubin, Shany Mugami, Cyrille J. Cohen, Julia Lipovetsky, Eran Sharon, Annat Raiter
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Oncoimmunology
article-version (VoR) Version of Record
Oncoimmunology
article-version (VoR) Version of Record
Breast cancer subtypes have not shown significant response to current immunomodulatory therapies. Although most subtypes are treatable, triple negative breast cancer (TNBC), an aggressive highly metastatic cancer, comprising 10–20% of breast cancer
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Background Breast cancer treatment is tailored to the specific cancer subtype. Often, systemic treatment is given prior to surgery. Chemotherapy induces significant endoplasmic reticulum (ER) stress-mediated cell death and upregulation of 78-kDa gluc
Publikováno v:
Blood. 138:4364-4364
Mantle cell lymphoma (MCL) is a difficult-to-treat B-cell malignancy characterized by the t(11,14) translocation, resulting in cyclin D1 (CD1) overexpression. In addition to CD1 overexpression, pathways such as the B-cell receptor, PI3K/AKT/ GSK3β,